Health ❯ Healthcare ❯ Regulatory Affairs ❯ FDA

Drug Recalls

FDA Class II Recall Targets Generic Vyvanse After Dissolution Failures

Testing found some capsules do not dissolve properly, risking reduced therapeutic effect.

FDA Class II Recall Issued for 141,984 Bottles of Generic Atorvastatin Over Dissolution Failures

FDA Class II Recall Targets 580,000 Prazosin Bottles for Nitrosamine Overages